<?xml version="1.0" encoding="UTF-8"?>
<p id="p0105">THC has the potential to deal with multidrug resistance in cancer in a unique way. It caused cell death through autophagy in Ara-C-resistant acute myeloid leukemia cancer cells [
 <xref rid="bib64" ref-type="bibr">64</xref>]. The photoactive metal complex of THC exhibited phototoxicity, which may have potential applications in photodynamic therapy [
 <xref rid="bib65" ref-type="bibr">65</xref>]. In a study, THC-loaded vaginal nanomicrobicide demonstrated the gp120-CD4 binding inhibitory ability, which showed its potential in the prophylaxis of HIV-1 infection associated with unprotected sex [
 <xref rid="bib66" ref-type="bibr">66</xref>]. Carboxymethylcellulose-THC, a synthetic conjugate prodrug, possessed targeted drug delivery capacity for colon cancer therapy even better than curcumin and THC [
 <xref rid="bib67" ref-type="bibr">67</xref>].
</p>
